• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Renal lithiasis: the internist's viewpoint 1986].

作者信息

Jaeger P

出版信息

Schweiz Med Wochenschr. 1986 Jul 8;116(27-28):902-8.

PMID:3738461
Abstract

This study is presented as a debate on nephrolithiasis by a urologist and an internist. The reason is that in 1986 the urologist has become successful at desintegrating almost any stone without open surgery, whereas the internist's approach to the same problem is entirely based upon an understanding of pathophysiological mechanisms. After having reviewed the major risk factors for renal stone disease, i.e. small urine volume, hypercalciuria, hyperoxaluria, hyperuricosuria, very high or very low urine pH and hypocitraturia, the author shows that now it is not only possible to selectively correct each of these disorders, but that in doing so the internist does change the natural history of the disease. For instance, definite remissions have been obtained by advising patients to increase water intake, by administering thiazides to hypercalciurics, pyridoxine to some hyperoxalurics, allopurinol to hyperuricosurics, urease inhibitors to struvite stone formers and citrate to hypocitraturics. Therefore, the author concludes that the role of the urologist and that of the internist are complementary: although the former now desintegrates the stone without open surgery, the latter, who takes care of the same patient next, is now largely able to prevent relapse of nephrolithiasis after determining the cause of the disease.

摘要

相似文献

1
[Renal lithiasis: the internist's viewpoint 1986].
Schweiz Med Wochenschr. 1986 Jul 8;116(27-28):902-8.
2
Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.枸橼酸钾疗法对钙结石形成的生理及物理化学纠正与预防作用
Trans Assoc Am Physicians. 1983;96:294-305.
3
[Comparative study of urinary calcium, oxalate and uric acid in calcium oxalate lithiasis].草酸钙结石患者尿钙、草酸和尿酸的对比研究
Nephrologie. 1984;5(5):189-91.
4
[Incidence of hyperoxaluria in idiopathic calcium nephrolithiasis].[特发性钙肾结石患者中高草酸尿症的发病率]
Schweiz Med Wochenschr. 1982 Dec 4;112(49):1795-8.
5
[Calcium lithiasis: uric acid under question].[钙结石:尿酸存疑]
Nephrologie. 1984;5(5):192-4.
6
Body size and 24-hour urine composition.身体大小与24小时尿液成分。
Am J Kidney Dis. 2006 Dec;48(6):905-15. doi: 10.1053/j.ajkd.2006.09.004.
7
Urinary risk factors for recurrent calcium stone formation in Thai stone formers.泰国结石患者复发性钙结石形成的尿液危险因素。
J Med Assoc Thai. 2007 Apr;90(4):688-98.
8
[Functional evaluation in patients with kidney calculi].[肾结石患者的功能评估]
Srp Arh Celok Lek. 1998 Sep-Oct;126(9-10):394-8.
9
Metabolic abnormalities associated with calyceal diverticular stones.与肾盏憩室结石相关的代谢异常。
BJU Int. 2006 May;97(5):1053-6. doi: 10.1111/j.1464-410X.2006.06134.x.
10
[Metabolic changes in 2612 patients with nephrolithiasis].[2612例肾结石患者的代谢变化]
Medicina (B Aires). 1999;59(5 Pt 1):417-22.